Zhihao Peter Qiu, CDER Office of Pharmaceutical Quality, shares regulatory requirements for biological products submitted under Biologics License Applications (BLAs), CDER biotech pre-license and pre-approval inspections, and common deficiencies.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: [ Ссылка ]
CDER SBIA 2020 Playlist: [ Ссылка ]
LinkedIn: [ Ссылка ]
Training resources: [ Ссылка ]
Twitter: [ Ссылка ]
CDER small business e-mail update subscription: [ Ссылка ]
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
![](https://s2.save4k.ru/pic/7i41v5xrM30/maxresdefault.jpg)